Education abounds at ICE/ENDO2014

ICE/ENDO 2014 is less than two months away, and I am looking forward to welcoming all of you to Chicago, my hometown, for a meeting that is destined to make history! Featuring the best in global endocrine research and practice, ICE/ENDO 2014 will provide attendees with countless opportunities to energize their basic and translational science and enhance their scholarly-based practice through top-notch science presentations, educational programs, and networking with colleagues from around the world.

The meeting will open with two plenary talks from Nobel Prize Win- ner Robert Lefkowitz, MD, and C. Ronald Kahn, MD, who will provide their expert perspectives on the history and future directions of research in the fields of G protein-coupled receptors and insulin signaling. A fantastic line-up of internationally renowned leaders in the fields of diabetes, metabolism, cancer, bone, and reproductive research, and hormone signaling will also present their work on our plenary stage at ICE/ENDO.

Researchers, make sure you attend the symposium “Navigating Biomedical Big Data” to learn how to access and analyze very large data sets and how to apply big data tools to your own research. We’ve also planned a new, unique opportunity for you to “Meet the NIH Program Directors” where you can learn about the missions of the National Institutes of Health and receive guidance on funding opportunities from representatives from the National Institute of Diabetes and Digestive and Kidney Dis- eases (NIDDK), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Heart, Lung and Blood Institute (NHLBI). In today’s challenging funding environment, this program is a must-attend for all research scientists!

For clinicians eager to keep current with the rapidly evolving nature of clinical practice, there are plenty of opportunities to hear the latest updates from the experts
during meeting program favorites like Meet-The-Professor sessions, Year-In sessions, and Clinical Prac- tice Guideline updates. The Master Clinician sessions will explore controversies surrounding the new lipid guidelines and the updated thyroid cancer guidelines. For clinicians who still have questions about ABIM requirements for Maintenance of Certifi cation, don’t miss “MOC Made Easy” and “Live Learning” ses- sions on how to navigate the process and earn certifi cation points. An exciting new addition to this year’s program is the symposium “Update in Endocrine and Metabolic Emer- gencies,” which will provide expert perspectives on the management of thyroid storm, hyponatremia, and inherited metabolic diseases.

Chicago is a fantastic location for our meeting, and I am sure that you will love discovering the world-class museums, dining, and entertainment the city has to offer. We are excited to host our endocrinology colleagues from the around the world at one of the largest annual meetings in the Society’s history!

Please feel free to share your comments, questions, and ideas about ICE/ENDO and the Endocrine Society by writing to me via

Teresa K. Woodruff, PhD
Endocrine Society

You may also like

  • Introducing the New President: Gary D. Hammer, MD, PhD

    The Endocrine Society is pleased to welcome its president for 2020–2021, Gary D. Hammer, MD, PhD, who took office at the Society’s virtual business meeting on April 6. As director of the Endocrine Oncology Program at the University of Michigan Rogel Cancer Center in Ann Arbor, his work on adrenal homeostasis focuses on progenitor cell…

  • Moving Forward: Strategic Plan is Right on Track

    The Society always invites your questions, comments, and solutions for improvement. This year especially, we proactively sought input into our Fourth Strategic Plan (SP4). We surveyed our membership, held focus group meetings (targeting international members and past leaders), and interviewed “lapsed” members and outside stakeholders (e.g. insurers, deans, pharma). The resulting input fed into the…